ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0026

A Modified Version of the 2016 ACR Fibromyalgia Criteria Cognitive Items Results in Stronger Correlation Between Subjective and Objective Measures of Cognitive Impairment

Valerie Aloush1, Chen Yaalon2, Sheer Raev2, Noy Sobol2, Jacob Ablin1, Ran Shorer3 and Odelia Elkana2, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Academic College Tel Aviv Jaffa, Tel Aviv, Israel, 3Tel Aviv Medical Center, Tel Aviv, Israel

Meeting: ACR Convergence 2020

Keywords: Cognitive dysfunction, Diagnostic criteria, fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Fibromyalgia & Other Clinical Pain Syndromes Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: In a previous study, we showed that the subjective item assessing cognitive impairment (SSS-Cog) for fibromyalgia (FM) did not correlate with objective cognitive measures. In the current study we describe two modifications designed to enhance this correlation: extending the current SSS-cog scale from 0-3 to 1-5, and a new questionnaire that specifically targets cognitive impairments associated with FM.

Methods: Sixty-two FM patients underwent a computerized cognitive assessment battery. FM symptoms were assessed on the Fibromyalgia Impact Questionnaire (FIQ); the Widespread Pain Index (WPI); the Symptom Severity Scale (SSS), the new SSS-Cog scale ranging from 1 to5, the Beck Depression Inventory (BDI) and the new cognitive questionnaire developed by the authors.

Results: Significant correlations were found between the new SSS-Cog scale, the global cognitive score and all indices [Global Score r= -. 532, p= .00; Indices: Memory r= -.305, p= .01; Executive function r = -.514, p= .00; Attention r = -.471, p= .00; Processing Speed r = -.468, p= .00; Motor Skills r= -.495, p= .00]. Significant correlations were found between the questionnaire items developed by the authors and the global cognitive score and all indices except the memory index [Global Score r= -. 522, p= .00; Indices: Memory r= -.163, p= .212; Executive function r= -.477, p= .00; Attention r= -.439, p= .00; Processing Speed r= -.496, p= .00; Motor Skills r= -.532, p= .00].

Conclusion: Given the simplicity of the extending scale, we suggest incorporating this modification into the American College of Rheumatology (ACR) FM diagnostic criteria.


Disclosure: V. Aloush, None; C. Yaalon, None; S. Raev, None; N. Sobol, None; J. Ablin, None; R. Shorer, None; O. Elkana, None.

To cite this abstract in AMA style:

Aloush V, Yaalon C, Raev S, Sobol N, Ablin J, Shorer R, Elkana O. A Modified Version of the 2016 ACR Fibromyalgia Criteria Cognitive Items Results in Stronger Correlation Between Subjective and Objective Measures of Cognitive Impairment [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/a-modified-version-of-the-2016-acr-fibromyalgia-criteria-cognitive-items-results-in-stronger-correlation-between-subjective-and-objective-measures-of-cognitive-impairment/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-modified-version-of-the-2016-acr-fibromyalgia-criteria-cognitive-items-results-in-stronger-correlation-between-subjective-and-objective-measures-of-cognitive-impairment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology